[PDF][PDF] Single-Shot ChAd3-MARV Vaccine in Modified Formulation Buffer Shows 100% Protection of NHPs. Vaccines 2022, 10, 1935
CL Finch, TH King, KJ Alfson, KA Albanese, JNP Smith… - 2022 - academia.edu
Marburg virus (MARV) is a virus of high human consequence with a case fatality rate of 24–
88%. The global health and national security risks posed by Marburg virus disease (MVD) …
88%. The global health and national security risks posed by Marburg virus disease (MVD) …
Single-shot ChAd3-MARV vaccine in modified formulation buffer shows 100% protection of NHPs
CL Finch, TH King, KJ Alfson, KA Albanese, JNP Smith… - Vaccines, 2022 - mdpi.com
Marburg virus (MARV) is a virus of high human consequence with a case fatality rate of 24–
88%. The global health and national security risks posed by Marburg virus disease (MVD) …
88%. The global health and national security risks posed by Marburg virus disease (MVD) …
A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates
R Hunegnaw, AN Honko, L Wang, D Carr… - Science translational …, 2022 - science.org
Marburg virus (MARV) causes a severe hemorrhagic fever disease in primates with mortality
rates in humans of up to 90%. MARV has been identified as a category A bioterrorism agent …
rates in humans of up to 90%. MARV has been identified as a category A bioterrorism agent …
Rapid and durable protection against Marburg virus with a single-shot ChAd3-MARV GP vaccine
R Hunegnaw, A Honko, L Wang, D Carr, T Murray… - bioRxiv, 2021 - biorxiv.org
Marburg virus (MARV) causes a severe hemorrhagic fever disease in primates with mortality
rates in humans up to 90%. Since 2018, MARV has been identified as a priority pathogen by …
rates in humans up to 90%. Since 2018, MARV has been identified as a priority pathogen by …
Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in …
Background WHO has identified Marburg virus as an emerging virus requiring urgent
vaccine research and development, particularly due to its recent emergence in Ghana. We …
vaccine research and development, particularly due to its recent emergence in Ghana. We …
[HTML][HTML] Complex adenovirus-vectored vaccine protects guinea pigs from three strains of Marburg virus challenges
D Wang, M Hevey, LY Juompan, CM Trubey, NU Raja… - Virology, 2006 - Elsevier
The Marburg virus (MARV), an African filovirus closely related to the Ebola virus, causes a
deadly hemorrhagic fever in humans, with up to 90% mortality. Currently, treatment of …
deadly hemorrhagic fever in humans, with up to 90% mortality. Currently, treatment of …
An introduction to the Marburg virus vaccine consortium, MARVAC
The emergence of Marburg virus (MARV) in Guinea and Ghana triggered the assembly of
the MARV vaccine “MARVAC” consortium representing leaders in the field of vaccine …
the MARV vaccine “MARVAC” consortium representing leaders in the field of vaccine …
A recombinant rabies virus expressing the Marburg virus glycoprotein is dependent upon ADCC for protection against Marburg virus disease in a murine model
R Keshwara, KR Hagen, T Abreu-Mota, AB Papaneri… - 2019 - repositorium.uminho.pt
Marburg virus (MARV) is a filovirus related to Ebola virus (EBOV) associated with human
hemorrhagic disease. Outbreaks are sporadic and severe, with a reported case mortality …
hemorrhagic disease. Outbreaks are sporadic and severe, with a reported case mortality …
ADVANCEMENTS IN MARBURG VIRUS VACCINE DEVELOPMENT: UNRAVELLING RECENT FINDINGS. A NARRATIVE REVIEW.
A Zaheer, DZ Hussain, A Akhtar - Student's Journal of Health …, 2024 - sjhresearchafrica.org
Abstract Marburg Virus Disease (MVD) is a lethal single-stranded RNA virus transmitted by
Egyptian rousette bats, causing 12 surges in Sub-Saharan Africa, including a recent …
Egyptian rousette bats, causing 12 surges in Sub-Saharan Africa, including a recent …
De novo syntheses of Marburg virus antigens from adenovirus vectors induce potent humoral and cellular immune responses
D Wang, AL Schmaljohn, NU Raja, CM Trubey… - Vaccine, 2006 - Elsevier
Marburg virus (MARV) is an African filovirus that causes a deadly hemorrhagic fever in
humans, with up to 90% mortality. Currently, there are no MARV vaccines or therapies …
humans, with up to 90% mortality. Currently, there are no MARV vaccines or therapies …